Like most middle schoolers, Maxim Glazunov has a reasonable dislike of needles. But the Holliston seventh-grader set that aside Thursday as he prepared for his first injection of Pfizer’s COVID-19 vaccine.
Loneliness, isolation and a lack of access to services -- these things all likely contributed to what looks to be a record number of deaths from opioid overdoses in Massachusetts last year.
A new study suggests COVID-19 cases should dramatically drop in the U.S. by July, but the outlook for fall could be dependent on vaccination rates and the degree of use of non-pharmaceutical interventions.
It’s another blow for adolescents who hate needles -- but a potentially powerful way to slow the spread of COVID-19.
Finally, the state seems to agree that the corner drug store can play an important role in the vaccination effort. In the past few weeks, independent pharmacies have received their first shipments of vaccine.
It is a blank that experts cannot accurately fill, though they’ve been trying for months: normalcy will return when __% of the population has immunity to COVID-19.
A new study suggests a sizable number of Americans are dealing with upper-level chronic pain nearly all the time.
At the moment, Boston’s overall vaccination rate is 55 percent, with 22 percent of the eligible population partially vaccinated; 33 percent fully vaccinated.
As of Wednesday morning, several mega-sites had thousands of open appointments: more than 13,000 in Danvers, more than 10,000 at the Natick Mall, and around 8,000 at Gillette Stadium.
We may not be out of the pandemic woods, but some light is coming through the trees, suggests Ashish Jha, MD, dean of Brown University’s School of Public Health.
/cloudfront-us-east-1.images.arcpublishing.com/cmg/7QOJU3BNCJERBNKJC5LWTBYFLU.png)